Literature DB >> 25869639

Long-term impact of childhood-onset type 1 diabetes on social life, quality of life and sexuality.

H Mellerio1, S Guilmin-Crépon2, P Jacquin3, M Labéguerie4, C Lévy-Marchal5, C Alberti2.   

Abstract

AIM: This study describes the socio-professional outcomes, health-related quality of life (HRQOL) and sexuality of adults with childhood-onset type 1 diabetes (T1D).
METHODS: The study participants (n=388), recruited from a nationwide registry (age: 28.5 ± 3.1 years; T1D duration: 17.0 ± 2.7 years), completed a questionnaire (198 items); the results were compared with the French general population using standardized incidence ratios (SIRs) and Z scores matched for age, gender and period with/without education levels and patterns of family life. Linear regression models also investigated correlates of SF-36 Physical (PCS) and Mental Composite Scores (MCS).
RESULTS: Compared with the French general population, education levels of people with T1D were similar, with 68.6% having at least a high-school diploma or higher (SIR: 1.06, 95% CI: 0.93; 1.20), as were also their patterns of family life. Unemployment was higher in T1D women (15.3%, SIR: 1.50, 1.00; 2.05), but not in T1D men (8.6%, SIR: 0.96, 0.51; 1.57). Social discrimination was more common (SIR: 5.64, 4.64; 6.62), and frequency of daily alcohol consumption was higher (SIR: men, 3.34, 2.38; 4.54; women, 6.53, 4.57; 12.99). PCS and MCS were decreased moderately (mean ± SD: 52.0 ± 7.5; mean Z score: -0.2, 95% CI: -0.3; -0.1) and substantially (mean ± SD: 42.1 ± 12.4; mean Z score: -0.7, -0.8; -0.6), respectively. Fatigue and abandoning sports were predictive of a lower HRQOL. Both men and women were more frequently dissatisfied with their sex life. Prevalence of sexual problems was higher in women (SIR for: dysorgasmia, 1.91, 1.21-2.88; decreased/loss of desire: 2.11, 1.35-3.08), but similar in men. Participants with T1D-related complications had preserved social outcomes, but altered HRQOL.
CONCLUSION: Young adults with T1D have satisfactory social participation. However, their higher alcohol consumption, lower MCS and frequent dissatisfaction with sexuality suggest a heavy impact of the disease on morale, especially in women. Improving the everyday well-being of these young adults represents a key challenge for diabetes healthcare.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Education; Long-term outcomes; Pediatric type 1 diabetes; Quality of life; Sexuality; Social status

Mesh:

Year:  2015        PMID: 25869639     DOI: 10.1016/j.diabet.2014.12.006

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  3 in total

1.  Development and validation of the self-management Barriers and Supports Evaluation for working-aged adults with type 1 diabetes mellitus.

Authors:  Elizabeth M Planalp; Harald Kliems; Betty A Chewning; Mari Palta; Tamara J LeCaire; Laura A Young; Elizabeth D Cox
Journal:  BMJ Open Diabetes Res Care       Date:  2022-01

2.  Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndrome.

Authors:  Vincent Audard; Hélène Mellerio; Marie-Sophie Meuleman; Sophie Guilmin-Crépon; Aurélie Hummel; Eric Daugas; Agnès Dumas; Fallou Leye; Jacques Dantal; Claire Rigothier; François Provot; Dominique Chauveau; Stéphane Burtey; Alexandre Hertig; Karine Dahan; Antoine Durrbach; Claire Dossier; Alexandre Karras; Dominique Guerrot; Vincent Esnault; Philippe Rémy; Ziad A Massy; Isabelle Tostivint; Marie-Pascale Morin; Philippe Zaoui; Olivier Fritz; Moglie Le Quintrec; Alain Wynckel; Aurélie Bourmaud; Olivia Boyer; Dil Sahali; Corinne Alberti
Journal:  J Nephrol       Date:  2021-07-05       Impact factor: 3.902

3.  The JUBILE cohort: Quality of life after more than 40 years with type 1 diabetes.

Authors:  Jean-Jacques Altman; Ralph Niarra; Beverley Balkau; Christophe Vincent-Cassy
Journal:  Diabet Med       Date:  2020-12-22       Impact factor: 4.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.